Richa Rajwanshi

Statistics

Publications

Citations

241

H-Index

Active since

2016

Affiliations

University of California, Los Angeles(Current)

Richa Rajwanshi is an author at University of California, Los Angeles specializing in pharmacotherapy, anti-cd20 therapy, and pregnancy adverse drug reaction reporting.

ORCID

Publications per year

2016–2021

Publications

Tocilizumab use in pregnancy: Analysis of a global safety database including data from clinical trials and post-marketing data

Maria Hoeltzenbein, Evelin Beck, Richa Rajwanshi et al. · Seminars in Arthritis and Rheumatism · 2016 · 151 citations

Medicine, Obstetrics, Pharmacotherapy +17

Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplant

Robert R. Redfield, Stanley C. Jordan, Stéphan Busque et al. · American Journal of Transplantation · 2019 · 79 citations · Full text

Pharmacy, Immunology, Pharmacokinetics +17

Population Pharmacokinetics and Exposure–Response Analyses for Venetoclax in Combination with R-CHOP in Relapsed/Refractory and Previously Untreated Patients with Diffuse Large B Cell Lymphoma

Divya Samineni, Weize Huang, Leonid Gibiansky et al. · Advances in Therapy · 2021 · 11 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +14

1–3 of 3